NetworkNewsBreaks Archive - Page 470 of 1739

ThursdayFeb 10, 2022 12:56 pm

NetworkNewsBreaks – SPYR Inc. (SPYR) Announces Expanded Airing of MagixDrive Commercial

SPYR (OTCQB: SPYR) (dba SPYR Technologies), a technology company whose subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar IoT smart home and connected car markets, has further expanded the airing schedule of its MagixDrive national commercial. The new set of airings will greatly widen the reach and visibility of MagixDrive, the flagship wireless CarPlay device and the first branded product from SPYR Technologies’ wholly owned subsidiary Applied Magix. “We were quite satisfied with the results from the first wave of our commercial’s broadcast. By further increasing both the reach and frequency, we hope…

ThursdayFeb 10, 2022 12:13 pm

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System

RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company's IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product…

ThursdayFeb 10, 2022 12:05 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Release Q2 Financial Report, Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has announced that it will report its second-quarter financial results next week on Feb. 15, 2022; the results will cover the period ending Dec. 31, 2021. The company has scheduled a conference call and webcast to discuss the report; the call will be held Feb. 15, 2021, at 2 p.m. ET. Those interested can dial +1 (855) 605-1745 (United States and Canada) or +1 (914) 987-7959 (international) using conference ID 8645175. In addition, the company’s full financial statements and related MD&A along with a replay of the…

ThursdayFeb 10, 2022 11:35 am

NetworkNewsBreaks — Growth Capital Acquisition Corp. (NASDAQ: GCAC) Stockholders Approve Move with Cepton Technologies, Featured in Gamechangers Interview

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a special purpose acquisition company (“SPAC”), has announced that, at its Feb. 9, 2022, special meeting, its stockholders voted to approve the proposed business combination with Cepton Technologies Inc. According to the announcement, holders of almost 73% of GCAC’s issued and outstanding shares cast votes at the meeting, with more than 93% voting to approve the move. Based on the resounding affirmative vote by stockholders, Growth Capital anticipates completing the business combination quickly, with the combined company being named Cepton Inc., with its common stock and warrants trading on the Nasdaq Capital Market under…

WednesdayFeb 09, 2022 2:27 pm

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Committed to Bringing Science-Backed Health Benefits to All, Reframing Psychedelic Conversation

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has sought to capitalize on the ongoing transformation within the mental health sector. The company is positioning itself as the United States’ leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation. This comes as Representative Earl Blumenauer recently circulated an open letter to his colleagues in Congress, urging them to join him in petitioning the DEA to permit terminally ill patients to use psilocybin as part of their treatment without fear of being federally prosecuted. Although the DEA has remained steadfast in…

WednesdayFeb 09, 2022 2:02 pm

NetworkNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Conference Series Offering Added Value to Budding Investor Community

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently hosted the inaugural Sequire Metals & Mining Conference. The one-day investor event, held via the Sequire Virtual Events platform, featured a number of prominent public mining companies and industry experts. SRAX’s Vice President of Community and Events, Morgan-Lee Fogg, considered the conference one of the fastest-growing events the company has ever hosted. Sequire has previously played host to major events, such as the 2021 LD Micro Event, a prominent three-day joint in-person and virtual investor conference held…

WednesdayFeb 09, 2022 1:03 pm

NetworkNewsBreaks – SEVEN20 Continues Pushing Industry Boundaries in Transition to Full Web3 Entertainment Company

Dean Wilson, founder and CEO of Seven20, today announced a brand transition into a full Web3 entertainment company. With Web3 as the common thread binding the business and its partners, Seven20 will focus on blockchain, the metaverse as well as its continued work in music via management, labels and publishing. Having been about independence since its inception, the Web3 transition is an important and natural next step for Seven20. Independence — the freedom and the right to own an individual’s content and monetize and distribute it at one’s own discretion with no intermediaries — is, in essence, what blockchain technology…

WednesdayFeb 09, 2022 12:52 pm

NetworkNewsBreaks – Joshua Gold Resources Inc. (JSHG) to Identify Potential Drill Targets at Seymour Lake Extension Property

Joshua Gold Resources (OTC: JSHG), an American gold and mineral exploration company headquartered in Canada, today announced that it will be conducting a Drone Magnetometer Survey on its 100% owned Seymour Lake Extension property. JSHG is commencing the survey in order to pinpoint potential lithium (“Li”) drill targets at its property situated in northwestern Ontario within the Caribou-Marshall Lake Greenstone Belt. The Seymour Lake Extension property is adjacent to Green Technology Metals’ Seymour Lake lithium deposit, estimated to contain 2 to 3 million tons of 1.25% lithium. “With the global surge in electric vehicle production, lithium prices have exploded as…

WednesdayFeb 09, 2022 12:30 pm

NetworkNewsBreaks – VPR Brands LP (VPRB) Unveils New Dissim Sport and Dissim Slim Lighters to ‘Best Focus Group’ for Pre-Launch Reaction

VPR Brands (OTC: VPRB) recently debuted its new Dissim Sport and Dissim Slim Line Lighters at the 2022 TPE Tobacco Plus Expo, held in Las Vegas from Jan. 26-28, 2022, and the Champs Trade Show on Feb. 2-5, 2022, at the Las Vegas Convention Center. According to the update, the Slim and Sport line within the Dissim family of lighters will launch with an opening price point between $8-$28 MSRP respectively and are expected to bring a new audience and open new distribution channels. “I personally attended TPE this year so I could interact with the distributors firsthand and gauge…

WednesdayFeb 09, 2022 12:27 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Granted US Patent Covering Lead Proprietary Compound for Treatment of Anxiety Disorders

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has been granted U.S. patent 11,242,318 to the company’s investigational deuterated dimethyltryptamine (“DMT”) compound CYB004. The patent, granted by the U.S. Patent and Trademark Office, strengthens the proprietary position of Cybin’s CYB004 as a deuterated DMT compound until 2041, covers composition of matter and protects the CYB004 drug substance as a putative new chemical entity. CYB004 is Cybin’s lead investigational proprietary DMT compound and in studies has shown potential efficacy at lower doses while also increasing the duration of drug effect providing a therapeutic profile that may…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks